Session

Survivorship in prostate cancer: "It's all about patients"

Poster Session 71

  • Location:
    Room Milan, North Hall (Level 1)
  • Chairs:
     R. Kirby, London (GB)
     S. MacLennan, Aberdeen (GB)
     B. Tombal, Brussels (BE)
  • Aims and objectives of this session

    To assess the patient’s perspective and expectation during treatment and follow-up.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
* 938
Prostate cancer-specific anxiety in long-term survivors after radical prostatectomy

By: Meissner V.H.1, Dinkel A.2, Marten-Mittag B.2, Gschwend J.1, Herkommer K.1

Institutes: 1Klinikum Rechts Der Isar, Technical University of Munich, Dept. of Urology, Munich, Germany, 2Klinikum Rechts Der Isar, Technical University of Munich, Dept. of Psychosomatic Medicine and Psychotherapy, Munich, Germany

* 939
Patients’ perspectives on the risks of localized prostate cancer treatments prior to making the treatment decision

By: Van Stam M-A.1, Van Der Poel H.2, Aaronson N.3, Horenblas S.2, Tillier C.2, Bosch J.4

Institutes: 1University Medical Center Utrecht, Dept. of Urology, Utrecht, The Netherlands, 2NKI-AvL, Dept. of Urology, Amsterdam, The Netherlands, 3NKI-AvL, Division of Psychosocial Research & Epidemiology, Amsterdam, The Netherlands, 4Umc Utrecht, Dept. of Urology, Utrecht, The Netherlands

940
Elderly prostate cancer patients in the Netherlands have a worse prognosis than younger patients: A population-based study

By: Vernooij R.1, Van Oort I.2, De Reijke T.3, Aben K.1

Institutes: 1Netherlands Comprehensive Cancer Organisation, Dept. of Research, Utrecht, The Netherlands, 2Radboud University Medical Centre, Dept. of Urology, Nijmegen, The Netherlands, 3Academic Medical Centre, Dept. of Urology, Amsterdam, The Netherlands

941
A multimodal supportive care intervention in men and their partners/carers affected by metastatic prostate cancer: A randomised controlled feasibility study

By: Paterson C., Primeau C., Nabi G.

Institutes: Ninewells Hospital, Dept. of Urology, Dundee, United Kingdom

942
Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy

By: Kretschmer A., Buchner A., Grabbert M., Sommer A., Herlemann A., Stief C.G., Bauer R.M.

Institutes: LMU-Klinikum der Universität München, Dept. of Urology, Munich, Germany

943
Impact of the perception of relationship cohesion (dyadic adjustment) on the quality of life (QoL) of patients with prostate cancer (PCa) receiving gonadotropin-releasing hormone (GnRH) agonist therapy

By: Droupy S.1, Pello-Leprince-Ringuet N.2, Perrot V.2, Descazeaud A.3

Institutes: 1Chu Carémeau, Dept. of Urology Androlgy, Nîmes, France, 2Ipsen Pharma, Dept. of Urology, Boulogne-Billancourt, France, 3University Hospital, Dept. of Urology, Limoges, France

944
Impact of implementing a goal directed holistic needs clinic on quality of life after robotic radical prostatectomy

By: Calleja E., Ferguson J., Aning J.

Institutes: Freeman Hospital, Dept. of Urology, Newcastle upon Tyne, United Kingdom

945
Why has he changed so much? Exploring cognitive impairments in prostate cancer survivors on ADT using virtual reality testing

By: Green J.1, Mills R.2, Holland A.3, Davies M.2, Edginton T.4, Jansari A.5

Institutes: 1Whipps Cross University Hospital, Dept. of Urology, London, United Kingdom, 2UEL, Dept. of Psychology, London, United Kingdom, 3Goldsmiths, Dept. of Psychology, London, United Kingdom, 4University of Westminster, Dept. of Psychology, London, United Kingdom, 5Goldsmith, Dept. of Psychology, London, United Kingdom

946
Psychosocial interventions to improve the quality of life for men with prostate cancer: A Bayesian network meta-analysis of 31 randomised controlled trails

By: Shi Q., Xiang T., Liangren L., Zhenhua L., Lu Y., Qiang W.

Institutes: West China Hospital – Sichuan University, Dept. of Urology, Chengdu, China

947
Safety and benefits of group based exercise in daily clinical practice for men with prostate cancer undergoing androgen deprivation therapy

By: Ostergren P.B.1, Ragle A-M.2, Jakobsen H.1, Klausen T.W.3, Vinther A.2, Sønksen J.1

Institutes: 1Herlev and Gentofte University Hospital, Dept. of Urology, Herlev, Denmark, 2Herlev and Gentofte University Hospital, Dept. of Rehabilitation, Herlev, Denmark, 3Herlev and Gentofte University Hospital, Dept. of Haematology, Herlev, Denmark

948
How do changes in erectile functioning affect self-esteem in older men with localized prostate cancer?

By: Hilger C., Burkert S., Kendel F.

Institutes: Charité – Universitätsmedizin Berlin, Dept. of Medical Psychology, Berlin, Germany

949
Estimation of outcomes of artificial urinary sphincter implantation - a multicenter prospective observational study

By: Kaiho Y.1, Masuda H.2, Takei M.3, Hirayama T.4, Mitsui T.5, Yokoyama M.2, Kawamorita N.1, Nakagawa H.1, Iwamura M.4, Shinohara N.5, Arai Y.1

Institutes: 1Tohoku University Graduate School of Medicine, Dept. of Urology, Sendai, Japan, 2Tokyo Medical and Dental University, Dept. of Urology, Tokyo, Japan, 3Harasanshin Hospital, Dept. of Urology, Fukuoka, Japan, 4Kitasato University School of Medicine, Dept. of Urology, Kanagawa, Japan, 5Hokkaido University Graduate School of Medicine, Dept. of Renal and Genitourinary Surgery, Sapporo, Japan

Personal perspective
 R. Kirby, London (GB)